Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs121913105
rs121913105
FGFR3
C 0.700 CausalMutation CLINVAR

dbSNP: rs121913482
rs121913482
FGFR3
T 0.700 CausalMutation CLINVAR

dbSNP: rs121913483
rs121913483
FGFR3
G 0.700 CausalMutation CLINVAR

dbSNP: rs28931614
rs28931614
FGFR3
A 0.700 CausalMutation CLINVAR

dbSNP: rs28933068
rs28933068
FGFR3
G 0.700 CausalMutation CLINVAR

dbSNP: rs28934571
rs28934571
TP53
A 0.700 CausalMutation CLINVAR

dbSNP: rs4647924
rs4647924
FGFR3
G 0.700 CausalMutation CLINVAR

dbSNP: rs587782329
rs587782329
TP53
0.020 GeneticVariation BEFREE Neither specific HPV-16 350G/T variants nor specific p53 genotypes were associated with a higher risk of developing CIN III or cervical cancer. 10644829

2000
dbSNP: rs1042522
rs1042522
TP53
0.100 GeneticVariation BEFREE We failed to confirm earlier reports of increased cervical cancer susceptibility in women who harbor the p53 P72R allele. 12142377

2002
dbSNP: rs1131691014
rs1131691014
TP53
0.100 GeneticVariation BEFREE We failed to confirm earlier reports of increased cervical cancer susceptibility in women who harbor the p53 P72R allele. 12142377

2002
dbSNP: rs878854066
rs878854066
TP53
0.100 GeneticVariation BEFREE We failed to confirm earlier reports of increased cervical cancer susceptibility in women who harbor the p53 P72R allele. 12142377

2002
dbSNP: rs1003897973
rs1003897973
TRIP10 ; LOC107985302
0.010 GeneticVariation BEFREE We failed to confirm earlier reports of increased cervical cancer susceptibility in women who harbor the p53 P72R allele. 12142377

2002
dbSNP: rs281860374
rs281860374
HLA-B ; HLA-C
0.010 GeneticVariation BEFREE We failed to confirm earlier reports of increased cervical cancer susceptibility in women who harbor the p53 P72R allele. 12142377

2002
dbSNP: rs9298814
rs9298814
IFNA17
0.010 GeneticVariation BEFREE Interferon, alpha 17 (IFNA17) Ile184Arg polymorphism and cervical cancer risk. 12490311

2003
dbSNP: rs1042522
rs1042522
TP53
0.100 GeneticVariation BEFREE Genetic polymorphisms of p73 G4C14-to-A4T14 at exon 2 and p53 Arg72Pro and the risk of cervical cancer in Japanese. 15036661

2004
dbSNP: rs1131691014
rs1131691014
TP53
0.100 GeneticVariation BEFREE Genetic polymorphisms of p73 G4C14-to-A4T14 at exon 2 and p53 Arg72Pro and the risk of cervical cancer in Japanese. 15036661

2004
dbSNP: rs1217691063
rs1217691063
MTHFR
0.100 GeneticVariation BEFREE The effect of methylenetetrahydrofolate reductase polymorphism C677T on cervical cancer in Korean women. 15581963

2004
dbSNP: rs878854066
rs878854066
TP53
0.100 GeneticVariation BEFREE Genetic polymorphisms of p73 G4C14-to-A4T14 at exon 2 and p53 Arg72Pro and the risk of cervical cancer in Japanese. 15036661

2004
dbSNP: rs587782329
rs587782329
TP53
0.020 GeneticVariation BEFREE The E6 variants T350G and A131G have been associated with increased oncogenic potential in cervical cancer patients depending on host genetic factors. 15006625

2004
dbSNP: rs786202962
rs786202962
TP53
0.010 GeneticVariation BEFREE The E6 variants T350G and A131G have been associated with increased oncogenic potential in cervical cancer patients depending on host genetic factors. 15006625

2004
dbSNP: rs1217691063
rs1217691063
MTHFR
0.100 GeneticVariation BEFREE In the present study, we have examined a large study population to determine whether the C677T polymorphism at the MTHFR locus affects susceptibility for cervical cancer or its precursor, cervical intraepithelial neoplasia (CIN). 15635481

2005
dbSNP: rs25487
rs25487
XRCC1
0.100 GeneticVariation BEFREE Association of XRCC1 Arg399Gln and OGG1 Ser326Cys polymorphisms with the risk of cervical cancer in Japanese subjects. 15990162

2005
dbSNP: rs1052133
rs1052133
OGG1 ; CAMK1
0.020 GeneticVariation BEFREE Association of XRCC1 Arg399Gln and OGG1 Ser326Cys polymorphisms with the risk of cervical cancer in Japanese subjects. 15990162

2005
dbSNP: rs25487
rs25487
XRCC1
0.100 GeneticVariation BEFREE XRCC1 R399Q polymorphism is associated with response to platinum-based neoadjuvant chemotherapy in bulky cervical cancer. 16875718

2006
dbSNP: rs759412116
rs759412116
ERCC2
0.010 GeneticVariation BEFREE XRCC1 R399Q polymorphism is associated with response to platinum-based neoadjuvant chemotherapy in bulky cervical cancer. 16875718

2006